These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12374587)

  • 1. Visual pathway glioma in children treated with chemotherapy.
    Demaerel P; de Ruyter N; Casteels I; Renard M; Uyttebroeck A; van Gool S
    Eur J Paediatr Neurol; 2002; 6(4):207-12. PubMed ID: 12374587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
    Packer RJ; Ater J; Allen J; Phillips P; Geyer R; Nicholson HS; Jakacki R; Kurczynski E; Needle M; Finlay J; Reaman G; Boyett JM
    J Neurosurg; 1997 May; 86(5):747-54. PubMed ID: 9126887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
    Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
    Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas.
    Mitchell AE; Elder JE; Mackey DA; Waters KD; Ashley DM
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):572-7. PubMed ID: 11902299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
    Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
    Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
    Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
    AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
    Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
    Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children.
    Kato T; Sawamura Y; Tada M; Ikeda J; Ishii N; Abe H
    J Neurooncol; 1998 May; 37(3):263-70. PubMed ID: 9524084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
    Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
    Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
    Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
    Nellan A; Wright E; Campbell K; Davies KD; Donson AM; Amani V; Judd A; Hemenway MS; Raybin J; Foreman NK; Rush S; Dorris K
    J Neurooncol; 2020 Jul; 148(3):569-575. PubMed ID: 32506370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
    Dufour C; Grill J; Lellouch-Tubiana A; Puget S; Chastagner P; Frappaz D; Doz F; Pichon F; Plantaz D; Gentet JC; Raquin MA; Kalifa C
    Eur J Cancer; 2006 Nov; 42(17):2939-45. PubMed ID: 16962317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
    Rakotonjanahary J; Gravier N; Lambron J; De Carli E; Toulgoat F; Delion M; Pellier I; Rialland X
    PLoS One; 2019; 14(3):e0212107. PubMed ID: 30849081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Salvage Treatment Strategies for Younger Children (<10 y of Age) With Progressive Low-grade Glioma After Initial Chemotherapy in North America: A Web-based Survey.
    Moorman B; Barbour M; Huang MA
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e141-e145. PubMed ID: 33235141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas.
    Lancaster DL; Hoddes JA; Michalski A
    J Neurooncol; 2003 Jul; 63(3):289-94. PubMed ID: 12892235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update.
    Packer RJ; Sutton LN; Bilaniuk LT; Radcliffe J; Rosenstock JG; Siegel KR; Bunin GR; Savino PJ; Bruce DA; Schut L
    Ann Neurol; 1988 Jan; 23(1):79-85. PubMed ID: 3345069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.